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Acute lung injury (ALI) is linked to mitochondrial
injury, resulting in impaired cellular oxygen utiliza-
tion; however, it is unknown how these events are
linked on the molecular level. Cardiolipin, a mito-
chondrial-specific lipid, is generated by cardiolipin
synthase (CLS1). Here, we show that S. aureus acti-
vates a ubiquitin E3 ligase component, Fbxo15, that
is sufficient to mediate proteasomal degradation of
CLS1 in epithelia, resulting in decreased cardiolipin
availability and disrupted mitochondrial function.
CLS1 is destabilized by the phosphatase and tensin
homolog (PTEN)-induced putative kinase 1 (PINK1),
which binds CLS1 to phosphorylate and regulates
CLS1 disposal. Like Fbxo15, PINK1 interacts with
and regulates levels of CLS1 through a mechanism
dependent upon Thr219. S. aureus infection upre-
gulates this Fbxo15-PINK1 pathway to impair mito-
chondrial integrity, and Pink1 knockout mice are
less prone to S. aureus-induced ALI. Thus, ALI-asso-
ciated disruption of cellular bioenergetics involves
bioeffectors that utilize a phosphodegron to elicit
ubiquitin-mediated disposal of a key mitochondrial
enzyme.INTRODUCTION
Acute lung injury (ALI) is a devastating disorder that occurs
most often from severe bacterial pneumonia or sepsis and is
commonly associated with multiorgan failure. One clinical hall-
mark of patients with ALI is a profound defect in cellular oxygen
consumption and extraction, termed cytopathic dysoxia, the476 Cell Reports 7, 476–487, April 24, 2014 ª2014 The Authorsmechanisms of which are not understood at the basic level (Loia-
cono and Shapiro, 2010; Samsel and Schumacker, 1991; Schu-
macker and Samsel, 1989; Shoemaker et al., 1993; Singer,
2007). Indeed, significant efforts to enhance tissue oxygenation
by increasing oxygen delivery in sepsis have proven ineffective,
indicating that a mitochondrial defect contributes to the pathobi-
ology of multiorgan failure. Thus, impaired oxygen utilizationmay
be due to mitochondrial abnormalities and ensuing epithelial
apoptosis, both of which have been extensively described in
ALI subjects (Brealey et al., 2002; Protti and Singer, 2006; Singer,
2007; Svistunenko et al., 2006). Type II alveolar epithelial cells
exhibit on a cellular basis the highest level of pulmonary oxygen
utilization and contain 50% of mitochondria in the lung (Crapo
et al., 1978, 1980; Massaro et al., 1975). Thus, an intact mito-
chondrial apparatus for oxygen utilization at the epithelial cellular
level is imperative for these cells to generate the chemical energy
needed to maintain pulmonary homeostasis.
Cardiolipin is an integral component of inner mitochondrial
membranes and essential for bioenergetics (Choi et al., 2007;
McMillin and Dowhan, 2002). Hence, cardiolipin deficiency is
lethal, as its impaired production is linked to impaired cell growth
and viability (Ostrander et al., 2001). A final step for de novomito-
chondrial synthesis of cardiolipin utilizes phosphatidylglycerol
and cytidine diphosphate choline-diacylglycerol as substrates
in a reaction catalyzed by the enzyme cardiolipin synthase 1
(CLS) (Schlame and Hostetler, 1997). The gene encoding CLS1
was recently cloned from yeast and mammalian sources, and
CLS knockdown results in impaired cell growth and viability
(Chang et al., 1998; Choi et al., 2007; Houtkooper et al., 2006;
Jiang et al., 1999; Lu et al., 2006). Interestingly, the CLS tran-
script (hCLS1) is ubiquitously expressed in tissues but low in
whole lung suggestive of its posttranslational regulation (Chen
et al., 2006). After initial de novo biosynthesis on the inner mem-
brane of mitochondria, cardiolipin undergoes further remodeling
in the mitochondria to incorporate unsaturated fatty acyl groups
that confer its structural and biologic activity; this remodeling is
catalyzed either by CLS1 itself, tafazzin, or lysocardiolipin acyl-
transferase (Nie et al., 2010; Xu et al., 2010). CLS1, however,
appears to exhibit reacylation activity for lysophosphatidylgly-
cerol rather than lysocardiolipin. The data suggest that, on one
hand, cardiolipin has a vitally important structural and physio-
logic role in mitochondria, as its deficiency leads to cytochrome
C release and apoptosis (Choi et al., 2007;McMillin andDowhan,
2002). However, because of its evolutionarily conserved resem-
blance to bacterial cardiolipin, the release of mammalian cardio-
lipin from dying cells into the extracellular space serves as a
highly potent mitochondrial-derived damage-associated molec-
ular pattern (DAMP-CL) that disrupts lung homeostasis (Ray
et al., 2010).
Ubiquitination of proteins brands them for degradation either
by the proteasome or via the lysosome (Tanaka et al., 2008).
The conjugation of ubiquitin to a target protein is orchestrated
by a series of enzymatic reactions involving an E1 ubiquitin-acti-
vating enzyme, ubiquitin transfer from an E1-activating enzyme
to an E2-conjugating enzyme, and last, generation of an iso-
peptide bond between the substrate’s ε-amino lysine and the
carboxyl-terminus of ubiquitin catalyzed by a E3-ubiquitin
ligase (Hochstrasser, 2000). Of the many E3 ligases, the SCF
superfamily is among the best studied (Tyers and Willems,
1999). The SCF complex has a catalytic core complex consisting
of Skp1, Cullin1, and the E2 ubiquitin-conjugating enzyme (Car-
dozo and Pagano, 2004; Zheng et al., 2002). The SCF complex
also contains an adaptor receptor subunit, termed F-box protein,
that targets hundreds of substrates through phosphospecific
domain interactions (Cenciarelli et al., 1999). F-box proteins
have two domains: an NH2-terminal F-box motif and a
carboxyl-terminal leucine-rich repeat motif or tryptophan-
aspartic acid (WD) repeat motif. The SCF complex uses the
F-box motif to bind Skp1, whereas the leucine-rich/WD repeat
motif is used for substrate recognition (Ilyin et al., 1999). How-
ever, there is a subclass of F-box proteins that lacks a distinct
carboxyl-terminal motif, thus named F-box domain only proteins
(Fbxos). Of this protein family, the promoter of FBXO15was used
as reporter to screen pluripotent cells (Okita et al., 2007);
the authentication of Fbxo15 as a ubiquitin E3 subunit and its
definitive substrate remains unknown, although a recent study
suggests it may control levels of p-glycoprotein (Katayama
et al., 2013).
Phosphatase and tensin homolog (PTEN)-induced putative
kinase 1 (PINK1) is a mitochondrial serine/threonine-protein
kinase encoded by the PINK1 gene (Unoki and Nakamura,
2001). Loss of function mutations in the PINK1 gene are critically
linked to mitochondrial dysfunction and early onset Parkinson’s
disease (Valente et al., 2004). PINK1 contains an NH2-terminal
mitochondrial-targeting sequence and is predicted to have an
important role in mitochondrial function (Mills et al., 2008).
PINK1 is able to access mitochondria to regulate degradation
of mitochondrial respiratory chain subunits (Vincow et al.,
2013). One model suggests that PINK1 accumulates on the
outer mitochondrial membrane after cell stress to recruit parkin
(a ubiquitin E3 ligase) and regulate mitochondrial removal by mi-
tophagy (Bu¨eler, 2009). Loss of function mutations in parkin are
also etiologically linked to familial forms of Parkinson’s disease
(Bonifati, 2005; Ziviani et al., 2010). To date, parkin, mitochon-drial protease HtrA2, mitochondrial chaperone TRAP1, and Akt
are the only known molecular targets described for Pink1 (Mur-
ata et al., 2011; Plun-Favreau et al., 2007; Pridgeon et al.,
2007; Sha et al., 2010). In this study, we have identified the phos-
phoenzyme CLS1 as a PINK1 target. PINK1 docks at a CLS1
sequence containing Thr219 to signal recruitment of Fbxo15 in
lung epithelial cells leading to ubiquitination and degradation
of CLS1, reduced cardiolipin synthesis, and apoptosis. More-
over, S. aureus infection exploits this PINK1-Fbxo15 pathway
to impair mitochondrial integrity and produce lung injury. These
results provide a unique mechanistic model for studying dysre-
gulated oxygenmetabolism and impairedmitochondrial integrity
observed in severe pneumonia-associated ALI.
RESULTS
CLS1 Is Essential forMaintaining Cardiolipin Production
and Mitochondrial Function
Human lung epithelial (A549) cells were transfected with control
plasmid, CLS1-small hairpin RNA (shRNA), or a plasmid encod-
ing the CLS1 gene. To examine de novo cardiolipin synthesis,
content of phospholipids was assessed by normal phase liquid
chromatography- mass spectrometry (MS) revealing decreased
cardiolipin and an increase in the substrate, phosphatidylgly-
cerol after CLS1-shRNA (Figure 1A). Further, CLS1-shRNA
resulted in reduced CLS1 protein levels, whereas CLS1 plasmid
overexpression increased cardiolipin synthesis and CLS1 pro-
tein levels (Figure 1B). Cells transfected with control shRNA or
CLS1-shRNAwere also assayed for ATP levels, indicating signif-
icantly decreased ATP levels with CLS1 knockdown, raising the
possibility that cell viability is impaired (Figure 1C). Indeed, CLS1
knockdown induced apoptosis indicated by caspase 3 cleav-
age (Figure 1D, arrows). To evaluate mitochondrial function,
transfected cells were stained with fluorescent DiOC2(3). A
low-fluorescent subpopulation was observed using fluores-
cence-activated cell sorting (FACS) with CLS1 knockdown,
which indicates mitochondrial membrane potential loss (Fig-
ure 1E). Interestingly, CLS1 knockdown also dramatically
changed the morphology of mitochondria within the cells from
healthy rod-shaped to large dense granules (Figure 1F). Last,
JC-1 dye was used to stain mitochondria. JC-1 is a cationic
dye that exhibits potential-dependent accumulation in mito-
chondria, indicated by a fluorescence emission shift from green
(525 nm) to red (590 nm). CLS1 knockdown led to mitochon-
drial depolarization as indicated by a decrease in the red/green
fluorescence intensity ratio (Figure 1G).
Fbxo15 Targets CLS1 Protein for Ubiquitination and
Degradation, therebyDisruptingMitochondrial Function
We embarked on an unbiased screen testing proteins that might
be involved in CLS1 degradation. Over 27 randomly selected
F-box proteins (FBXL, FBXW, and FBXO family members) were
ectopically expressed in lung epithelial cells (Figures S1A–
S1C) and cells collected and lysates analyzed for expression
of F-box proteins and endogenous CLS1. Only expression of
Fbxo15 decreased CLS1 levels. To confirm the specificity of
Fbxo15 targeting, we performed coimmunoprecipitation (co-IP)
experiments. A549 cells were lysed and subjected to CLS1 IP.Cell Reports 7, 476–487, April 24, 2014 ª2014 The Authors 477
Figure 1. CLS1 Is Essential for Preserving Mitochondrial Function and Structure
(A) A549 cells were transfected with control plasmid shRNA,CLS1-shRNA, or a plasmid encodingCLS1 for 48 hr. Shown is LC-MS assessment of cardiolipin and
phosphatidylglycerol in A549 cells. Typical negative-mass spectra of cardiolipin (left, CL) and phosphatidylglycerol (right, PG) obtained from A549 cells above.
Below is shown content of CL and PG in control A549 cells and cells after knockdown ofCLS1. Content of phospholipids was assessed by normal-phase LC-MS.
The results are presented as mean ± SD; n = 3. Statistical analyses were performed by Student’s t test. The statistical significance of differences was set at
p < 0.05.
(B) A549 cells were transfectedwith control (CON) plasmid,CLS1-shRNA, or a plasmid encodingCLS1 for 48 hr. Cells were also labeledwith [3H]-palmitic acid for
an additional 24 hr after plasmid transfection. Cells were collected and lipids extracted and separated by thin-layer chromatography (TLC). The lipids were
quantified using a plate reader, and the radioactivity of the spots was counted and graphed (results are presented as mean ± SE; n = 3 experiments; *p < 0.05
versus CON). Below: cell lysates were assayed for levels of immunoreactive hCLS1 and actin proteins.
(C) ATP levels were assayed in cells using the Cell-Glo ATP assay following the manufacturer’s protocol (results are presented as mean ± SE; n = 5 experiments;
*p < 0.01 versus CON). RLU, relative light units.
(D) A549 cells were transfected with control shRNA or CLS1-shRNA for 48 hr, and cells were collected and assayed for caspase 3 immunoblotting, indicating
cleavage products (arrows).
(E) A549 cells were transfected with control shRNA or CLS1-shRNA for 48 hr, and cells were stained with fluorescent DiOC2(3) dye followed by FACS analysis.
(F) Cells were stained with MitoTracker Green to visualize mitochondria; cells were then analyzed by confocal microscopy.
(G) A549 cells were stained with JC-1 dye; the fluorescence emission at channel green (525 nm) and red (590 nm) was recorded. Scale bar represents 10 mM.Of six E3 ligases subunits tested, only Fbxo15 was detected in
association with CLS1 (Figure S1D). Further, ectopic Fbxo15
expression significantly decreased half-life (t1/2) of CLS1 (Fig-
ure 2A). Addition of the proteasomal inhibitor, MG132, to cells478 Cell Reports 7, 476–487, April 24, 2014 ª2014 The Authorsled to a significant increase in CLS1 protein half-life, whereas
this was not seen with the lysosomal inhibitor, leupeptin (Fig-
ure 2B). Thus, endogenous Fbxo15 targets CLS1 for possible
ubiquitination. To identify the ubiquitination acceptor site within
Figure 2. Fbxo15 Targets CLS1 Protein for Ubiquitination and Degradation to Disrupt Mitochondrial Function
(A) CLS1 protein half-life determination with Fbxo15 overexpression or without (CON; n = 3 experiments; *p < 0.01 versus CON).
(B) CLS1 protein half-life determination using cyclohexamide (CHX) without or with MG132 or leupeptin (LEU) (n = 3 experiments; *p < 0.01 versus CON).
(C and D) A549 cells were transfected with control shRNA, Fbxo15-shRNA, or a plasmid encoding Fbxo15 for 48 hr. Cells were labeled with [3H]-palmitic acid for
additional 24 hr. Cells were collected and lipids extracted and separated by TLC. The TLC plate was quantified using a plate reader, the radioactivity of spots
counted and graphed in (D), and samples processed for immunoblotting below (n = 3 experiments; *p < 0.05 versus CON or empty plasmid).
(E and F) A549 cells were transfected with Fbxo15 before staining with MitoTracker Green (E) or JC-1 (F).
(G) A549 cells were transfected with increasing amounts of Fbxo15 plasmid before staining with DIOC2(3); cells were then analyzed by FACS.
(H) ATP levels were assayed in Fbxo15-transfected A549 cells using a Cell-Glo ATP assay (n = 5 experiments; *p < 0.01 versus CON).
(I) Cells were transfected with increasing amounts of Fbxo15 plasmid. Cells were collected and cell lysates analyzed for V5, CLS1, and b-actin immunoblotting
(n = 2). Scale bar represents 10 mM.
Results in (A), (B), (D), and (H) are presented as mean ± SE.CLS1, a candidate-mapping approach was used where CLS1
lysine mutants were constructed and synthesized in vitro before
testing using ubiquitination assays (Figure S2A). Of several CLS1
point mutants tested, only CLS1-K174R exhibited partial resis-
tance to SCFFbxo15-directed polyubiquitination (Figure S2B).
Finally, the K174R mutant exhibited an extended t1/2 compared
to wild-type CLS1 (Figure S2C).
To evaluate the biological role of Fbxo15, A549 cells were
transfected with an empty plasmid, Fbxo15-shRNA, or a plasmid
encoding the Fbxo15 gene prior to assays for cardiolipin syn-
thesis. Fbxo15 plasmid expression significantly decreased car-
diolipin synthesis and CLS1 protein levels, whereas Fbxo15
knockdown significantly increased cardiolipin production andCLS1 protein levels (Figures 2C and 2D). Hence, Fbxo15
regulates cardiolipin biosynthesis via CLS1 in cells. Next, cells
were transfected with Fbxo15 plasmid to assess mitochondrial
morphology. Interestingly, ectopic expression ofFbxo15plasmid
dramatically changed the morphology of mitochondria within
cells from healthy rod-shaped structures to large dense granules
(Figure 2E). JC-1 staining revealed that Fbxo15 plasmid overex-
pression leads to mitochondrial depolarization as indicated
by a decrease in the red/green fluorescence intensity ratio (Fig-
ure 2F). These results were also confirmed by FACS analysis
and DiOC2(3) staining indicative of a low-fluorescent subpopula-
tion with Fbxo15 plasmid overexpression, suggestive of mito-
chondrial membrane potential loss (Figure 2G). Fbxo15 plasmidCell Reports 7, 476–487, April 24, 2014 ª2014 The Authors 479
Figure 3. PINK1 Regulates CLS1 Protein Stability
(A) A549 cells were collected followed by coimmunoprecipitation of endogenous CLS1 and then probed with phospho antibodies in immunoblotting. IB,
immunoblotting; IgG, immunoglobulin G; NS, nonspecific bands.
(B) Cells were collected followed by coimmunoprecipitation of endogenous CLS1 and then probed for kinases in immunoblotting.
(C) In vitro kinase assay. CLS1 protein was incubated with immunoprecipitated PINK1 and [32P]g-ATP under different assay conditions. Reaction mixtures were
then resolved on SDS-PAGE before CLS1, PINK1 immunoblotting, and autoradiography.
(D and E) PINK1 was immunoprecipitated using PINK1 antibody and coupled to IgG beads. PINK1 beads were then incubated with in-vitro-synthesized products
expressing his-V5-CLS1 mutants (top blots). After washing, proteins were eluted and processed for V5-CLS1 immunoblotting (bottom blots).
(F) Cells were transfected with empty plasmid, control shRNA,PINK1-shRNA, or a plasmid encoding PINK1 for 48 hr. Cells were labeled with [3H]-palmitic acid for
an additional 24 hr. Cardiolipin synthesis was assayed and graphed (n = 3 experiments; *p < 0.05 versus CON or empty).
(G) ATP levels were assayed in transfected cells (n = 5 experiments; *p < 0.01 versus empty). Results in (F) and (G) are presented as mean ± SE.
(H and I) A549 cells were transfected with PINK1 plasmid before being stained with MitoTracker Green (H) or JC-1 (I). Scale bar represents 10 mM.overexpression also significantly decreased ATP levels (Fig-
ure 2H) coupled with a dose-dependent decrease in immunore-
active CLS1 content (Figure 2I).
PINK Regulates CLS1 Stability
To determine the Fbxo15 docking site within the CLS1, a deletio-
nal mapping approach was used where truncated CLS1mutants
were constructed and synthesized in vitro. These synthesized
his-tagged mutant CLS1 proteins were then subjected to copur-
ification with Fbxo15 using a cobalt column. All CLS1 constructs
were successfully synthesized in vitro, and CLS1 C200 and
C150 mutants lacked ability to bind Fbxo15 (Figure S3A). Thus,
Fbxo15 docks within the enzyme spanning the region of 200–
250 amino acids (aas) within CLS1. Closer examination of this
region revealed several potential phosphorylation sites deter-
mined by a Net-Phos program (Blom et al., 1999). Site-directed
mutagenesis of candidate CLS1 phosphorylation sites was per-
formed, followed by in vitro synthesis and copurification with
Fbxo15 using a cobalt column. Of several mutants tested, only
a CLS1-T219A lacked ability to bind Fbxo15 (Figure S3B).
Thus, T219 within CLS1 serves as a potential molecular recogni-
tion site for Fbxo15, consistent with the behavior of SCF mem-
bers to target phosphodegrons within substrates. Alternatively,
this site could serve as a docking or phosphorylation site for a
kinase that regulates binding of Fbxo15 to CLS1 indirectly.
To first identify if CLS1 is phosphorylated, A549 cells were
lysed and subjected to CLS1 IP and samples probed using phos-
pho-threonine antibodies; the results revealed a band that480 Cell Reports 7, 476–487, April 24, 2014 ª2014 The Authorsmigrates at the predicted size of CLS1 (Figure 3A). To identify
a kinase that phosphorylates CLS1, we performed co-IP exper-
iments. A549 cells were lysed and subjected to CLS1 IP and
samples also probed with antibodies against several candidate
kinases. Of seven kinases tested, only PINK1 was detected in
the CLS1 immunoprecipitates (Figure 3B). In vitro kinase assays
using recombinant proteins under various control conditions
indicated that PINK1 directly phosphorylates CLS1 (Figure 3C).
Additional mapping and pull-down studies indicated that
PINK1 kinase also docks within the 200–250 aas region of
CLS1 requiring T219 (Figures 3D and 3E). Similar to Fbxo15,
knockdown of PINK1 kinase using shRNA increased CLS1
levels, whereas overexpression of PINK1 plasmid decreased
CLS1 levels (Figure S4A). Last, protein half-life studies demon-
strated that the T219A CLS1 mutant exhibited a significantly
extended t1/2 compared to wild-type enzyme and other mu-
tants tested (Figures S4B and S4C). Physiologically, PINK1
plasmid expression in cells reduced cardiolipin synthesis, ATP
levels, and mitochondrial morphologic integrity (Figures 3F–3I),
whereas PINK1 knockdown stimulated cardiolipin synthesis
(Figure 3F). Additional studies suggest that CLS1 is degraded
within the cytosol rather than in the mitochondria because
ectopic PINK1 or Fbxo15 plasmid expression was sufficient to
reduce immunoreactive CLS1 in soluble fractions of cells and
Fbxo15 levels were not detected in mitochondria even after
ectopic Fbxo15 plasmid expression (Figures S5A and S5B).
Last, PINK1 depletion using shRNA resulted in reduced levels
of polyubiquitinated CLS1 suggesting that the kinase was
Figure 4. S. aureus Impairs Cardiolipin Biosynthesis and Mitochondrial Function
(A)S. aureuswas given tomice (13 107 cfus/mouse i.t.) for 3 hr and 6 hr. Mice were euthanized and lungs harvested and assayed for CLS1, Fbxo15, PINK1, actin,
and phospho-threonine (phospho-T) protein levels.
(B) Lung tissues from (A) were collected, lysed, and subjected to CLS1 IP, followed by Fbxo15, PINK1, actin, and phospho-threonine immunoblotting. HC, heavy
chain; LC, light chain.
(C and D) A549 cells were infected with S. aureus at moi = 10 and 100 for 16 hr before labeling with [3H]-palmitic acid and assayed for cardiolipin production (C)
and secretion (D).
(E) Cells were transfected with CON shRNA, PINK1-shRNA, and/or Fbxo15-shRNA before exposure to S. aureus (S. au). Cells were then stained with JC-1 and
observed under confocal microscopy.
(F) A549 cells were transfected with plasmids encoding either Fbxo15 or PINK1 or exposed to S. aureus at moi = 50 for 16 hr; cells were washed and analyzed
using Seahorse technology to measure oxygen consumption rates.
(G) A549 cells were transfectedwith either empty plasmid orCLS1 plasmid for 24 hr before exposure toS. aureus at moi = 20 or 100. Cells were then collected and
assayed for ATP levels and CLS1 immunoblotting. n = 3 experiments; *p < 0.05 versus 0 moi.
(H) Human lungs (n = 6 control and six pneumonia lung tissue samples) were assayed for CLS1, Fbxo15, and PINK1 protein levels by immunoblotting; relative
protein levels were graphed using densitometry (n = 3 in C, D, and G; n = 4 in F; n = 6 in H; *p < 0.05 versus CON in C, D, F, and H; data presented as mean ± SE).
Scale bar represents 10 mM.required for Fbxo15 recruitment to the cardiolipin biosynthetic
enzyme (Figure S5C).
S. aureus Activates an Fbxo15/PINK1 Pathway to Impair
Mitochondrial Function via CLS1
When S. aureus was given to mice (13 107 colony-forming units
[cfus]/mouse intratracheally [i.t.]) for 3 hr or 6 hr, immunoblotting
revealed increased levels of Fbxo15 and PINK1 in whole-lung
samples (Figure 4A) and increased association of Fbxo15 toCLS1 that also was bound to PINK1 (Figure 4B). S. aureus
increased CLS1 phosphorylation (Figure 4B).To evaluate effects
of S. aureus on murine epithelia, lung type II cells were isolated
and cultured with the pathogen. We observed morphologic
changes and depolarization in mitochondria by MitoTracker
and JC-1 staining (Figure S6A). Similarly, S. aureus also
increased levels of immunoreactive Fbxo15 and PINK1 and
decreased levels of CLS1 in murine type II cells (Figure S6B).
S. aureus also reduced cardiolipin production and increasedCell Reports 7, 476–487, April 24, 2014 ª2014 The Authors 481
Figure 5. Fbxo15 Produces Acute Lung
Injury
(A) C57BL6 mice (n = 4 mice/group) were given
empty virus or a lentivirus encoding Fbxo15 (108
plaque-forming units/mouse) for 96 hr. Mice were
euthanized and lungs were assayed for Fbxo15
and CLS1 by immunoblotting.
(B–E) Before euthanization, animals were me-
chanically ventilated using Flexivent and lung
compliance (B and D), resistance (C), and ela-
stance (lung stiffness, E) were measured and
graphed.
(F and G) Lavage protein and total cells counts.
(H) Lung edema. Mice were assessed for Evans
Blue dye extravasation in lung fluid. (*p <
0.05 versus empty in C–H; data presented as
mean ± SE).release of this mitochondrial-specific DAMP into culture me-
dium (Figures 4C and 4D). JC-1 staining revealed that double
knockdown of Fbxo15 and PINK1 protein attenuated mito-
chondrial depolarization caused by S. aureus (Figure 4E). Impor-
tantly, oxygen consumption rates in cells were significantly
reduced by PINK1 or Fbxo15 plasmid overexpression or after
S. aureus infection (Figure 4F). These results correlated with
decreased cardiolipin mass in cells after PINK1 or Fbxo15
plasmid overexpression (Figure S6C). Further, expression
of CLS1 plasmid in cells was sufficient to rescue S. aureus-
induced decreases in ATP production (Figure 4G). Immunoblot
analysis from subjects with pneumonia revealed increased
PINK1 and Fbxo15 content and decreased CLS1 protein levels
in lung tissue (Figure 4H).
Lentiviral Fbxo15 Gene Transfer Induces Acute Lung
Injury
To assess the biological significance of Fbxo15, we expressed
the F box protein in vivo. We hypothesized that Fbxo15
gene transfer will decrease CLS1 protein levels, thus reducing
mitochondrial function, accentuating pulmonary injury. In mice,
lentiviral Fbxo15 gene transfer decreased CLS1 protein levels
(Figure 5A). These effects were associated with increased lung
resistance and elastance (lung stiffness), decreased compliance
(volume/pressure; Figures 5B–5E), and increased lavage protein
concentration and lavage cell counts (Figures 5F and 5G); the F
box protein also significantly produced pulmonary edema evi-
denced by extravasation of Evans blue dye into the lung fluid
(Figure 5H). Thus, overexpression of Fbxo15 mimics many of
the physiologic effects seen with S. aureus infection in vivo.482 Cell Reports 7, 476–487, April 24, 2014 ª2014 The AuthorsPink1 Knockout Mice Have
Reduced Severity of S. aureus-
Induced Acute Lung Injury
To assess the biological significance of
PINK1, mice deficient in the kinase were
infected with S. aureus (Figure 6). The
baseline levels of values of lung me-
chanics in control mice differed in
Pink1/ mice versus mice examined in
Figure 5 because of experimental design(strain differences; all mice were infected with S. aureus). Never-
theless, Pink1/ mice compared to wild-type littermates had
better compliance and reduced lung resistance and elastance
(Figures 6A–6D) and decreased lavage protein concentration
(Figure 6E). Interestingly, lavage cell counts, bacterial load, and
lung histology was not altered between the groups (Figures
6F–6H). Importantly, levels of cardiolipin in lung fluid were signif-
icantly reduced in Pink1/ mice versus wild-type mice (Fig-
ure 6I), consistent with reduced mitochondrial injury. These
results suggest that PINK1 regulates vulnerability to microbial
lung injury with limited effects on alveolar inflammation. More-
over, the upregulation of PINK1 by S. aureus plays an important
role in the pathophysiology of this infection. However, these
studies were not designed to assess the long-term effects of
PINK1 depletion on other parameters such as survival after
S. aureus infection. This will be important to fully understand
the biological role of this kinase in experimental pneumonia.
DISCUSSION
A profound mitochondrial defect exists during ALI and multior-
gan failure, the molecular basis of which is unknown. Here, we
show that S. aureus infection of epithelia implicated in severe
ALI degrades the indispensable mitochondrial enzyme, CLS1,
required for cardiolipin biosynthesis. S. aureus is a major cause
of nosocomial and community-acquired pneumonia but also se-
vere sepsis and endocarditis (Watkins et al., 2012). S. aureus-
induced pneumonia is common and potentially life-threatening
(Osiyemi and Dickinson, 2000; Ragle et al., 2010; Rello et al.,
2005; Sidorova and Domnikova, 1999). In recent years, more
Figure 6. Pink1-Deficient Mice Have Less Pulmonary Injury after S. aureus Infection
Wild-type (WT) and PINK1 knockout mice (n = 6 mice/group) were infected with S. aureus (105 cfus/mouse i.t.) for 24 hr. Mice were then mechanically ventilated
using Flexivent and lung compliance (A and B), resistance (C), and elastance (D) were measured and graphed. Lavage protein, cells counts, lavage bacterial
loads, and lung histology are shown in (E)–(H). Cardiolipin (CL) levels are shown in (I) (*p < 0.05 versus WT in A–E, I; data presented as mean ± SE).and more S. aureus isolates exhibit methicillin resistance, further
presenting a significant challenge in its eradication. Thus, based
on its importance in the clinical arena and ability to trigger a
mitochondrial apoptotic pathway, this pathogen was selected
to assess effects on cardiolipin metabolism (Haslinger et al.,
2003). We provide evidence of the molecular regulation of
CLS1 protein, demonstrating that a poorly characterized F box
protein, Fbxo15, is recruited to CLS1, resulting in its poly-
ubiquitination and proteasomal elimination. Indeed, Thr219 within
CLS1 is a critical molecular recognition or docking site for PINK1;
this site also signals Fbxo3 recruitment leading to CLS1 poly-
ubiquitination at K174. Fbxo15 alone is sufficient to signif-
icantly impair mitochondrial oxygen utilization and lung stability,
whereas PINK1 is required to mediate adverse effects of
S. aureus on pulmonary injury. As a whole, our data suggest
that S. aureus severely disrupts cardiolipin biosynthesis perhaps
through ubiquitination at the CLS1 step, which then leads
to extracellular release of preformed cardiolipin (Figures 4D
and 7). We have previously shown that extracellular cardiolipin
potently disrupts lung homeostasis and recapitulates many fea-
tures of pneumonia (Ray et al., 2010). Hence, our data suggest
that, as onemechanism, severe bacterial infection triggers phos-
phorylation-dependent ubiquitination of a key substrate (CLS1)as a means to release a mitochondrial-derived DAMP to elicit
pulmonary dyshomeostasis.
Aside from few initial studies (Chen et al., 2006; Su and Dow-
han, 2006), the structure-function and posttranslational control
of CLS1 is largely unknown. There appears to be tight coordina-
tion between translation and transcription of CLS in yeast (Su and
Dowhan, 2006). Further, thyroxine has been shown to increase
hepatic enzyme activity (Hostetler, 1991) and lipopolysaccharide
decreases CLS mRNA levels in the liver (Lu et al., 2011). CLS1
normally resides within the inner membrane of mitochondria
(Chen et al., 2006), where it could potentially colocalize with a
pool of PINK1 (Meissner et al., 2011). However, due to lack of
a canonical mitochondrial targeting signal, it is unlikely that
Fbxo15 traffics inside themitochondria.More likely, ourdata sug-
gest that Fbxo15 mediates ubiquitinylation and degradation of
CLS1 within the endoplasmic reticulum (ER) after its biosyn-
thesis, perhaps as a feedback regulatory mechanism. Indeed,
fractionation studies suggest thatmitochondria are devoid of sig-
nificant concentrations of Fbxo15 under native conditions or after
ectopic expression of Fbxo15 (Figure S5). Yet F box protein or
PINK1 plasmid expression reduces CLS1 immunoreactive levels
in the cytosol and in the mitochondria (Figure S5). These results
suggest that, once Fbxo15-mediated CLS1 depletion occurs inCell Reports 7, 476–487, April 24, 2014 ª2014 The Authors 483
Figure 7. Model of Mitochondrial Damage during ALI
S. aureus infection induces expression of a kinase, PINK1, that phosphorylates
an indispensable protein CLS1, which in turn triggers CLS1 ubiquitination
and degradation by the F box protein (SCFFbxo15), leading to decreased car-
diolipin production, extracellular release of a preformed pool of cardiolipin, and
mitochondrial dysfunction. Fbxo15-PINK1 activation may contribute to cyto-
pathic dysoxia observed in pneumonia. This pathway partakes in the patho-
biology of pneumonia and acute lung injury (ALI).the ER, this limits enzyme targeted tomitochondria. Thismodel is
supported by recent evidence of crosstalk and physical contact
sites between mitochondria and the ER that facilitate phospho-
lipid synthesis (Friedman et al., 2011). We cannot exclude a
mechanismwhereby PINK1-induced CLS1 phosphorylation trig-
gers a structural or conformational change in CLS1 to stimulate
its release from the inner membrane to the outer membrane of
mitochondria, making it accessible for Fbxo15 targeting. In this
way, CLS1 ubiquitination by Fbxo15 would mimic interaction on
the outer mitochondrial membrane between mitofusin with the
E3 ligase component, parkin (Ziviani et al., 2010).
Cardiolipin is synthesized via the biosynthetic pathway
involving CLS1 but then is remodeled on the outer mitochondrial
membrane by additional enzymes. Our data suggest a central
role for CLS1 in preserving mitochondrial integrity in human
lung epithelia, as knockdown of CLS1 reduces cardiolipin pro-
duction, decreases cardiolipin mass, and leads to loss of mito-
chondrial functionality. Even though overexpression of CLS1
increases cardiolipin production and total cardiolipin levels in
cells (Chen et al., 2006), other related enzymes involved in its
remodeling, including lysocardiolipin acyltransferase or tafazzin,
might also be critical targets for E3 ligases. However, decreased
total cardiolipin mass (Figure S6C) in cells correlates with
reduced CLS1 protein and Fbxo15 and PINK1 appear to selec-
tively target CLS1 (data not shown), underscoring the physiolog-
ical importance of the CL biosynthetic pathway in lung epithelia.
The connection between the de novo and remodeling pathway
for cardiolipin synthesis and molecular regulation of related
enzymes requires further investigation.
Loss of function mutations in PINK1 gene are major causes of
mitochondrial dysfunction resulting in some forms of Parkinson’s
disease (Valente et al., 2004). However, here, overexpression of
PINK1 caused mitochondrial depolarization and significantly
reduced cellular oxygen consumption via triggering CLS1 degra-484 Cell Reports 7, 476–487, April 24, 2014 ª2014 The Authorsdation (Figure 4F). The ability of PINK1 to mediate turnover of
mitochondrial proteins is not unusual given its role in modulating
stability of membrane-bound respiratory chain subunits (Vincow
et al., 2013). Further, compared to wild-type littermates,
Pink1/ mice were less prone to S. aureus-induced injury, as
reflected by better lung mechanics and lower protein concentra-
tions, with no effect on inflammatory cell recruitment in lung fluid.
These results suggest that S. aureus primarily impairs lung
biophysical properties (e.g., reduces surfactant activity) in a
PINK1-dependent manner. Interestingly, S. aureus also exploits
PINK1 to phosphorylate other substrates such as AKT and Par-
kin, as PINK1 knockdown effectively preventsS. aureus-induced
phosphorylation of AKT and Parkin (Figure S7).
Importantly, cardiolipin levels were reduced in lung fluid of in-
fected Pink1/ mice versus control mice, indicating that PINK1
depletion attenuates the ability of S. aureus to trigger release of
cardiolipin-DAMP. Hence, PINK1 depletion may be protective to
microbial virulence under some conditions and its varying roles
might simply relate to differences in the cellular systems studied.
This is similar to the effects of PINK1 on mitochondrial fission, in
which apparently opposite effects are observed in cultured
mammalian neurons compared to Drosophila muscle and sper-
matids (Dagda et al., 2009; Deng et al., 2008; Lutz et al., 2009).
In this regard, a key feature of lung epithelia is that they are highly
enriched with mitochondria, suggesting a need in these cells
for mechanisms to provide feedback inhibition to ensure tight
homeostatic control of levels of proteins within themitochondrial
apparatus. Hence, PINK1 and Fbxo15 might represent a consti-
tutive mechanism to limit an overabundance of CLS1, and yet
this pathway could to be exploited in settings of pulmonary
inflammation during severe infection with highly virulent bacterial
pathogens.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
A549 cells were cultured in F12/K medium (Gibco) supplemented with 10%
fetal bovine serum. For half-life studies, cells were treated with cycloheximide
(40 mg/ml) at different time points in blankmedium. Cells lysates were prepared
by brief sonication in 150 mM NaCl, 50 mM Tris, 1.0 mM EDTA, 2 mM dithio-
threitol, 0.025% sodium azide, and 1 mM phenylmethylsulfonyl fluoride
(buffer A) at 4C. All plasmids were delivered into cells using Fugene 6HD.
All plasmid constructs were generated using PCR-based strategies using
appropriate primers; point mutants were generated using a site-directed
mutagenesis kit (Chen and Mallampalli, 2009).
S. aureus Infection
A549 or murine type II cells were cultured in 6-well dishes at 0.5 million cells/
plate for 24 hr before infection. S. aureus (A) was purchased from American
Type Culture Collection (ATCC). Inoculums were freshly prepared prior to
experiments using frozen stocks of S. aureus (ATCC strain 29213, frozen at
midlog phase; optical density 625 = 0.8). S. aureus was maintained in tryptic
soy broth minimal agar. Cultures were plated and grown overnight from frozen
stock. Overnight plate cultures were then inoculated in tryptic soy broth and
grown by rotary shaking at 37C to log phase. Cells were then infected with
S. aureus at multiplicity of infection (moi) = 10, 50, or 100 for 1, 2, or 16 hr.
Coimmunoprecipitation
Five hundredmicrograms of total protein from cell lysates was precleared with
20 ml of protein A/G beads for 1 hr at 4C. Five micrograms of primary antibody
was added for 18 hr incubation at 4C. Forty microliters of protein A/G beads
were added for an additional 6 hr of incubation. Beads were slowly centrifuged
and washed five times using 50 mM HEPES, 150 mM NaCl, 0.5 mM EGTA,
50 mM NaF, 10 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 20 mM leu-
peptin, and 1% (v/v) Triton X-100 (radio-immunoprecipitation assay) buffer, as
described (Mallampalli et al., 2000). The beads were heated at 100C for 5 min
with 80 ml of protein sample buffer prior to SDS-PAGE and immunoblotting.
CLS1 (Novus; Santa Cruz Biotechnology), Fbxo15 (Novus; GeneTex), and
PINK1 primary antibodies (Abcam) were used at 1:500 to 1:1,000 dilution in
immunoblotting.
Mass Spectrometry and Liquid Chromatography
Cellular lipids were extracted using the method of Folch (Folch et al., 1957).
Cardiolipin resolved using high-performance thin-layer chromatography and
analyzed by liquid chromatography (LC)/MS using a Prominence high-perfor-
mance liquid chromatography system (Shimadzu) with a reverse phase C8
column (Luna; 5 micron; 4.6 mm 3 15 cm; Phenomenex). An isocratic solvent
system (2-propanol: water: triethylamine: acetic acid; 450:50:2.5:2.5; v/v/v/v)
was used at a flow rate of 0.4 ml/min. Spectra were analyzed on Q-TOF
Premier mass spectrometer (Waters). Parameters of MS and details were
described previously (Tyurina et al., 2011).
Microscopy and Immunostaining
All themicroscopywork was performed using a Nikon A1 confocal microscope
using a 603 oil objective. Themicroscope was equipped with Ti Perfect Focus
system and Tokai Hit live cell chamber providing a humidified atmosphere at
37Cwith 5%CO2. Transfected cells (23 10
5) were plated at 70% confluence
on 35mmMatTek glass bottom culture dishes before being labeled with either
MitoTracker Red (1:5,000) or JC-1 (1:100) for 20 min. Image analysis was by
Nikon NIS-element and ImageJ software.
Mitochondrial Lipids and Bioenergetics
A549 cells were transfected with control shRNA, Fbxo15-shRNA or PINK1
shRNA, or plasmids encoding either Fbxo15 or PINK1 for 48 hr. Cells were
labeled with [3H]-palmitic acid for additional 24 hr for determination of cardio-
lipin synthesis. Cells and medium were collected and lipids extracted and
separated by thin-layer chromatography (TLC) (Ray et al., 2010). Individual
phospholipids on the TLC plates were quantified using a plate reader. ATP
was assayed using a CellTiter-Glo Assay kit (Promega). Oxygen consumption
in cells was assayed using an XF Analyzer (Seahorse Biosciences).
Animal Studies
Male C57LB/6 mice (purchased from Jackson Laboratories) were acclimated
at the University of Pittsburgh Animal Care Facility and maintained according
to all federal and institutional animal care guidelines and under a University of
Pittsburgh Institutional Animal Care and Use Committee-approved protocol.
Pink1 knockout mice are maintained as a heterozygous line on a C57/129
background and crossed to generatePink1+/+ and Pink1/ littermates (Dagda
et al., 2011). Mice were deeply anesthetized with ketamine (80–100 mg/kg
of body weight, intraperitoneally [i.p.]) and xylazine (10 mg/kg, i.p.), and then
the larynx was well visualized under a fiber optic light source before endotra-
cheal intubation with a 3/400 24-gauge plastic catheter. Replication-deficient
lentivirus (Lenti) alone or Lenti-Fbxo15 (108 plaque-forming units in 50 ml of
PBS) was instilled i.t. on day 1, after which animals were allowed to recover
for 96 hr before FlexiVent studies (Chen et al., 2011).
Human Samples
Human lung samples were obtained from the University of Pittsburgh
Health Sciences Tissue Bank. The control subjects’ ages ranged from 50 to
62, whereas in pneumonia subjects, the ages ranged from 12 to 60. All sub-
jects were Caucasian and female, except one male in the control group. The
study was approved both by the University of Pittsburgh Tissue Utilization
Committee and University of Pittsburgh Institutional Review Board.
Statistical Analysis
Statistical comparisons were performed with the Prism program, version 4.03
(GraphPad Software) using an ANOVA 1 or an unpaired 2 t test with p < 0.05
indicative of significance.SUPPLEMENTAL INFORMATION
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